Fig. 3.
Comparison of cancer therapies. For the parameter setting of Fig. 2D, different therapies are compared via 1,000 forward simulations with . Shown is the fraction of runs that have not yet developed a metastasis mutation as a function of elapsed time. All-out maximum dosage therapy is only slightly better than no therapy in avoiding metastasis. Much better is metronome therapy with with almost 70% success rate (values numerically optimized). Adaptive therapy removes the tumor in close to 90% of runs.